Selection of blockbuster announcements

1. Junshi biology: VV116 has completed a phase III clinical study comparing PAXLOVID for early treatment of mild to moderate COVID-19 patients with severe progression, including high risk factors for death.

$JUNSHI BIO (01877.HK)$Announced that the company's holding subsidiary Shanghai Juntuo Biopharmaceutical Technology Co., Ltd. ("Juntuo Biology") and Suzhou Wangshan Wangshui Biopharmaceutical Co., Ltd. ("Wangshan Wangshui") developed oral nucleoside anti-SARS-CoV-2 drug VV116 tablets (project code: JT001/VV116). "VV116") has completed a phase III clinical study (NCT05341609, the "JT001-010 study") comparing the Nimatervir / ritonavir tablet combination (PAXLOVID) for early treatment in patients with mild to moderate novel coronavirus infection ("COVID-19") who progressed to severe stage including high risk factors for death, while several international multicenter phase III clinical studies of VV116 have been conducted in different populations.

2. Sinopharm Group: the distribution and exclusive import rights of anti-novel coronavirus oral drug Monoravir capsules developed jointly by Mercedes and Ridgeback in mainland China

$SINOPHARM (01099.HK)$It is announced that the company's controlling shareholder, China Pharmaceutical Group Co., Ltd. has signed a cooperation framework agreement with Merck & Co Inc in September 2022, and has been granted the distribution and exclusive import rights in Chinese mainland of the anti-novel coronavirus oral drug Monoravir capsule (trade name: Lizhuiri ®/ LAGEVRIO ®) developed by Mershadong in cooperation with Ridgeback Biotechnology.

Byd Company Limited sold 1.8635 million new energy vehicles in 2022, an increase of 208.64% over the same period last year.

$BYD COMPANY (01211.HK)$It is announced that in December 2022, car production totaled 235215 vehicles, an annual increase of 141.8%. Among them, the company achieved the production of 235200 new energy vehicles. In 2022, the cumulative automobile production was 1.8817 million, an annual increase of 151.7 percent, and the cumulative sales volume was 1.8685 million, an increase of 152.5 percent. Of this total, 1.877 million new energy vehicles were produced, and 1.8635 million new energy vehicles were produced and sold, an increase of 209.2% and 208.6% respectively.

4. NIO Inc. delivered a total of 122500 cars in 2022, an increase of 34% over the same period last year.

$NIO-SW (09866.HK)$It was announced that NIO Inc. delivered 15800 cars in December 2022, a record monthly delivery and a year-on-year increase of 50.8%. 40052 cars were delivered in the fourth quarter, up 60% year-on-year, setting a record for quarterly deliveries. A total of 122486 vehicles were delivered in 2022, an increase of 34 per cent. As of the 31st of last month, the cumulative delivery volume was 289556 vehicles.

5. Li Auto Inc. delivered a total of 133200 vehicles in 2022, an increase of 47.2% over the same period last year.

$Li Auto-W (02015.HK)$It was announced that the company delivered a total of 21233 new cars in December 2022, the highest monthly delivery record again and a year-on-year increase of 50.7%. A total of 46319 vehicles were delivered in the fourth quarter, an increase of 31.5% over the fourth quarter of 2021. In 2022, a total of 133246 vehicles were delivered, an annual increase of 47.2%. As of December, the cumulative delivery volume was 257334.

6. China Railway Construction Corporation: the total investment of the consortium in winning the bid is about 30.353 billion yuan.

$CHINA RAIL CONS (01186.HK)$Notice, recently, the company's subordinate China Railway Construction Corporation Kunlun Investment Group Co., Ltd. and Guangxi Road and Bridge Engineering Group Co., Ltd. formed a consortium to win the Luzhou-Gulin highway project. The winning project includes two parts: Luzhou-Gulin highway project (hereinafter referred to as Lugu highway project) and G93 Chengdu-Chongqing ring highway new Naxi Metro Interchange project (hereinafter referred to as Metro Interchange Project). The total investment of the winning project is about 30.353 billion yuan, of which the investment of Lugu highway project is estimated to be about 30.056 billion yuan, and that of Metro Interchange project is estimated to be about 297 million yuan. The project adopts the mode of "BOT+EPC+ government subsidy", and the return way is "user pay". The construction period of Lugu highway project is 4 years, the charging period is 29 years and 325 days, and the construction period of Metro Interchange project is 1.5 years. The project capital accounts for 20.2% of the total investment. The registered capital of the project company is tentatively set at 100 million yuan, all funded by social capital. During the construction period, the government subsidy is about 1.1 billion yuan. The remaining funds other than the above-mentioned funds shall be raised by the project company as the main body of financing through bank loans and other means.

Important matters

Qiu Ti Technology (01478): the listing of Kunshan Qiu Ti from China to Shenzhen Stock Exchange is officially accepted by China Securities Regulatory Commission.

China Electric Power (02380): to acquire a controlling stake in Jinzishan Wind Power

Jinyu Group (02009): approval of subsidiary Beijing inspection to be listed on the new third board

Zhongda Group Holdings (00139): plans to carry out local live broadcast service business

Genscript Biotech Corporation (01548): the application for the listing of new drugs submitted by Cedar Orange was accepted by the State Drug Administration.

China Evergrande New Energy Vehicle (00708): Hengchi 5 is in mass production and has delivered 324 vehicles

Resume trading and suspend trading

China Olympic Garden (03883): nearly 90% of real estate projects are carried out according to plan and schedule, and trading continues to be suspended.

Xinsheng Mining (02133): the Stock Exchange agrees to extend the resumption period and continue to suspend trading

Huazhang Technology (01673): keep doing business as usual and continue to suspend trading

Investment and operation

Gome Retail (00493): interest-free loan provided by Huang Guangyu, the controlling shareholder, totaling HK $630 million in December

Gome Retail (00493): plans to issue 4.063 billion shares to Global Capital to settle outstanding debts

China Shenhua Energy (01088): unit 2 of Beihai Power Plant passed 168h trial operation.

MGM China (02282): return the casino area and related entertainment equipment

SJM Holdings (00880): SJM will pay annual royalties to the Macao government for the use of casinos

Melco International Development (00200): the 10-year betting grant granted to Melco Macau came into effect on January 1.

Junshi Bio (01877): notice of acceptance of Drug Clinical trial Application for JS010 injection

BeiGene, Ltd. (06160): the application for listing license for new indications of Bai Zean ®for the treatment of HCC has been accepted in China.

Time Electric (03898): received a total of 262 million yuan in government subsidies.

Zhongmin Holdings (00681): affiliated contract for natural gas purchase and sale

Shanghai Industrial Environment (00807): the first sewage treatment project in Sichuan Province

Gurley Pharmaceuticals-B (01672): Viking has filed several complaints against the group's drug candidates ASC41 and ASC43F to the company and others.

Xiexin New Energy (00451): subsidiary plans to sell all the shares of Xiexin Photovoltaic in Dengkou and 51% of Yuncheng Xinhua Energy Development.

CNOOC Petrochemical (03983): complete the full circulation of some unlisted shares of the company.

Strength Development (01277): fit invested a total of US $91.4132 million in tobacco products manufacturing and wholesale business

Hong Kong Aerospace Technology (01725): plans to sell all shares in Positive Expert for HK $75 million

Swire A (00019) and Swire B (00087): complete the acquisition of Coca-Cola Company bottling business in Vietnam

Swire A (00019) and Swire B (00087): equity transfer relating to CCBMH restructuring has been completed

Increase and decrease holdings

Shanghai Fudan (01385): four partnerships have reduced their holdings by 32.5523 million shares, and the reduction plan has been completed.

Operation data

Midea Home (03990): contract sales of about 79.24 billion yuan in 2022

Equity incentive

Li Auto Inc.-W (02015): grant 10.8316 million restricted shares

China Xinlianxin Chemical Fertilizer (01866): adopt the subsidiary equity incentive plan to encourage the target to subscribe for Henan Xinlianxin international trade with an additional registered capital of 7.45 million yuan.

Jiele Group (00341): granting share options to subscribe for 24.87 million shares

Hisense Home Appliances (00921): it is recommended to adopt the 2022 A-share restricted Stock incentive Plan

JD Health (06618): award 1.454 million award shares

JD Logistics, Inc. (02618): award 5.2386 million award shares

Repurchase cancellation

KE Holdings Inc.-W (02423): buy back 435000 shares with US $2 million on December 30th

Tencent (00700): repurchased 1.05 million shares at a cost of HK $353 million on December 30th

AIA Group Limited (01299): repurchased 2.5786 million shares at a cost of HK $225 million on December 30th

AAC Technologies Holdings Inc. (02018): repurchased 1.5 million shares at a cost of HK $26.533 million on December 30th

Sinotrans (00598): buy back 3.7272 million shares at a cost of HK $14.22 million on December 30th

Xiexin Technology (03800): buy back 12 million shares on December 30th

DongFeng Motor Group (00489): repurchased 1.33 million shares at a cost of HK $5.9699 million on December 30th

Blue River Holdings (00498): repurchased 5.62 million shares at a cost of HK $5.18 million on December 30th